Does GHK‑Cu (copper peptide) interact with fluoxetine (Prozac)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Clinically Significant Interaction Between GHK-Cu and Fluoxetine (Prozac)

There is no documented drug interaction between GHK-Cu (copper peptide) and fluoxetine (Prozac), and concurrent use appears safe based on available evidence.

Mechanism and Pharmacology

GHK-Cu is a naturally occurring tripeptide with copper-binding properties that functions primarily through:

  • Anti-inflammatory pathways 1, 2
  • Gene expression modulation 3, 4
  • Antioxidant mechanisms 5, 2
  • Tissue regeneration effects 3, 6

GHK-Cu does not interact with serotonergic pathways, cytochrome P450 enzymes, or other mechanisms relevant to fluoxetine metabolism 7.

Fluoxetine's Key Interaction Pathways

Fluoxetine's clinically significant interactions occur through:

  • CYP2D6 metabolism: Fluoxetine is metabolized by CYP2D6 and can interact with other drugs using this pathway 8, 7
  • Serotonergic activity: Risk of serotonin syndrome when combined with MAOIs or other serotonergic agents 8
  • Protein binding: 94.5% protein-bound, potentially interacting with other highly protein-bound drugs 7

GHK-Cu does not affect any of these pathways [1-2].

Absence of Contraindications

The comprehensive guidelines on fluoxetine safety specifically list substances requiring caution:

  • MAOIs (contraindicated) 8
  • Other serotonergic drugs (SSRIs, SNRIs, TCAs, tramadol, dextromethorphan) 8
  • St. John's wort, L-tryptophan 8
  • Drugs metabolized by CYP2D6 8, 9

Peptides like GHK-Cu are notably absent from these lists 8.

Clinical Considerations

Safety Profile

  • GHK-Cu has demonstrated a favorable safety profile in multiple studies without reports of drug interactions 3, 2
  • The peptide's primary actions are localized to tissue regeneration and cellular protection 3, 4
  • No evidence suggests GHK-Cu affects neurotransmitter systems or hepatic metabolism [1-2]

Monitoring

While no specific monitoring is required for this combination, standard fluoxetine monitoring remains appropriate:

  • Watch for typical SSRI adverse effects (nausea, insomnia, sexual dysfunction) 8, 10
  • Monitor for serotonin syndrome symptoms if other serotonergic agents are added 8
  • No additional monitoring needed specifically for GHK-Cu co-administration

Common Pitfall to Avoid

Do not confuse GHK-Cu with serotonergic supplements (such as L-tryptophan or St. John's wort, which DO interact with fluoxetine). GHK-Cu is a copper-binding peptide with entirely different mechanisms of action [1-2].

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.